Search PDMR transactions

Notifier
Name of person with notification obligation
Renée Aguiar Lucander
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Renée Aguiar Lucander
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Hansa Biopharma AB
Issuer´s LEI code
549300LLEO25ZJJ3NT91
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Hansa Biopharma AB SE0002148817 Acquisition 47,000 Quantity 31.98 SEK 25/09/2026 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Hansa Biopharma AB SE0002148817 Acquisition 25/09/2026 NASDAQ STOCKHOLM AB 47,000 (Quantity) 31.98 SEK
Total: 47,000
<< Back